From today, the Australian government will expand Pharmaceutical Benefit Scheme (PBS) access to the drug Keytruda for three additional types of cancer. This is part of a broader shift away from cancer ...
Interim data from a large trial showed the experimental vaccine, when combined with Merck's blockbuster immunotherapy Keytruda, helped reduce the risk of melanoma recurrence and spread in ‌patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results